ORIC - Oric Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ORIC is currently covered by 9 analysts with an average price target of $18.05. This is a potential upside of $12.97 (255.31%) from yesterday's end of day stock price of $5.08.

Oric Pharmaceuticals 's activity chart (see below) currently has 35 price targets and 63 ratings on display. The stock rating distribution of ORIC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.88% with an average time for these price targets to be met of 202.56 days.

Highest price target for ORIC is $22, Lowest price target is $12, average price target is $18.29.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 08-May-2025. First documented stock forecast 18-May-2020.

Currently out of the existing stock ratings of ORIC, 39 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$16.92 (333.07%)

$21

2 days ago
(08-May-2025)

6/22 (27.27%)

$16.92 (333.07%)

221

Buy

$12

$6.92 (136.22%)

$15

5 days ago
(05-May-2025)

1/5 (20%)

$6.96 (138.10%)

351

Buy

2 months 15 days ago
(25-Feb-2025)

1/2 (50%)

$10.03 (201.81%)

350

Buy

$22

$16.92 (333.07%)

$21

2 months 15 days ago
(25-Feb-2025)

2/7 (28.57%)

$13.7 (165.06%)

322

Buy

$20

$14.92 (293.70%)

$20

8 months 1 days ago
(09-Sep-2024)

2/6 (33.33%)

$10.04 (100.80%)

146

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ORIC (Oric Pharmaceuticals ) average time for price targets to be met?

On average it took 202.56 days on average for the stock forecasts to be realized with a an average price target met ratio 36.88

Which analyst has the current highest performing score on ORIC (Oric Pharmaceuticals ) with a proven track record?

ANUPAM RAMA

Which analyst has the current lower performing score on ORIC (Oric Pharmaceuticals ) with a proven track record?

MATTHEW BIEGLER

Which analyst has the most public recommendations on ORIC (Oric Pharmaceuticals )?

Anupam Rama works at JPMORGAN and has 26 price targets and 14 ratings on ORIC

Which analyst is the currently most bullish on ORIC (Oric Pharmaceuticals )?

Michael Ulz with highest potential upside - $19.92

Which analyst is the currently most reserved on ORIC (Oric Pharmaceuticals )?

Kevin Degeeter with lowest potential downside - -$0

Oric Pharmaceuticals  in the News

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on May 1, 2025 (the “Grant Date”), ORIC granted a total of 32,400 non-qualified stock options and 5,200 restricted stock...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?